MedPath

Circulatory Function in Laparoscopic Radical Cystectomy for Bladder Cancer

Completed
Conditions
Circulatory Function
Laparoscopic Radical Cystectomy for Bladder Cancer
Registration Number
NCT03892031
Lead Sponsor
RenJi Hospital
Brief Summary

To optimize the perioperative management of patients undergoing laparoscopic radical cystectomy(LPC) for bladder cancer through observation of perioperative changes of Brain Natriuretic Peptide(BNP), stroke volume variation(SVV), central venous pressure(CVP) and the use of transthoracic echocardiography(TTE).

Detailed Description

Long term pneumoperitoneum and steep trendelenburg in LPC for bladder cancer influence perioperative circulatory function, resulting in a series of pathophysiological changes. BNP is of high sensitivity and specificity in the evaluation of cardiac function. SVV and CVP are dynamic and static indices to predict fluid responsiveness. TTE is a good indicator of volume and cardiac function.Thus, we conducted the trial to assess the perioperative circulatory function in patients undergoing LPC. We hypothesized that long term pneumoperitoneum and steep trendelenburg in LPC for bladder cancer would increase perioperative blood volume and influence cardiac function.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
186
Inclusion Criteria
  • undergoing laparoscopic radical cystectomy for bladder cancer
  • ASA I-II
Exclusion Criteria
  • Cardiac insufficiency
  • Hepatic insufficiency
  • Renal insufficiency

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Brain Natriuretic Peptide(BNP)before induction (T1), at the end of operation(T2), at 12 hours (T3) and 24 hours (T4) postoperatively

To observe the change of BNP perioperatively.

Central Venous Pressure(CVP)before induction (T1),at the end of operation (T2), at 12 hours (T3) and 24 hours (T4) postoperatively

To observe the change of CVP perioperatively.

Stroke Volume Variation(SVV)before induction (T1), at the end of operation (T2)

To observe the change of SVV perioperatively.

Transthoracic Echocardiographybefore induction (T1),at the end of operation (T2), at 12 hours (T3) and 24 hours (T4) postoperatively

To observe the change of End-diastolic volume(EDV) perioperatively

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Renji Hospital, School of Medicine, Shanghai Jiaotong University, China

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath